Background: Chickenpox caused by Varicella Zoster Virus (VZV) leads to significant morbidity and mortality in immunosuppressed children (1,2). Rheumatological diagnosis potentially entails a difficult prolonged journey of immunosuppressive treatment, exacerbated by the significant threat of chickenpox exposure. Ultimately this leads to children missing school to avoid exposure, having blood tests to establish VZV serostatus, taking prophylaxis and interrupting immunosuppressive treatment. Whilst live attenuated VZV vaccination exists, it is not currently part of the immunisation schedule in the United Kingdom (UK) (1,3). In immunosuppressed children live vaccinations are also avoided due to risk of disease activation and therefore chickenpox exposure requires active management. Aciclovir and/or Varicella Zoster Immunoglobulin (VZIG) have been established for use in VZV Post Exposure Prophylaxis (PEP) (4, 5) . However there appears to be inconsistency within UK Paediatric Rheumatology units in the approach to PEP for immunosuppressed children. Public Health England (6) has recently issued guidance supporting the use of VZIG within 7 days of exposure in immunosuppressed patients who have a negative history of varicella/vaccination and are VZV IgG negative. Aciclovir is permitted as an alternative in individuals beyond 7 days of exposure; recognised as current practice in many specialist centres (6). Aims: This work forms part of an MSc project with Leeds University which aims to evaluate the use of PEP for VZV contact in children who are immunosuppressed following anti-rheumatic treatment.
Methods: This project consists of three parts: a systematic review of the evidence; a UK survey of current Paediatric Rheumatology practices; and development of a best practice guideline.
Results: The systematic review demonstrated insufficient evidence to support the use of PEP for immunosuppressed children. Despite this aciclovir and VZIG are established PEP treatments in the UK. Further high quality studies in the form of Randomised Controlled Trials (RCTs) may be ethically too futile; therefore evidence from large observational studies may be more appropriate. The UK survey showed an overall lack of consensus in Paediatric Rheumatology practices and a perceived need for national guidance. Important shortcomings in practices were demonstrated including potential failure to identify seronegative patients prior to commencing treatment and household and medical team contacts. This reflects the lack of secure evidence base highlighted in systematic review. Conclusions: This project identified both a lack of evidence to conclusively state the optimal PEP for immunosuppressed children, as well as a failure to implement a standard practice across the UK. It may be challenging to alter current practice, but dissemination of this project and the implementation of a nationally agreed guideline specific to paediatric rheumatology patients would be extremely helpful. In order to facilitate this, a proposed evidence-informed guideline will be presented within this work. This will facilitate standardised practice and UK wide collaboration within paediatric rheumatology. Background: The diagnosis of sacroiliitis in adolescents is challenging. The presence of inflammatory symptoms in the history may be helpful. Clinical examination is often unreliable with the predictive values of tests, such as the sacroiliac joint (SIJ) compression test, unknown. Radiographs of the maturing SIJ are difficult to interpret as widening of the joint and indistinct cortices are normal features of the immature skeleton. MRI has helped to improve the accuracy in diagnosing sacroiliitis in this age group. Aims: The aim of this study was to determine whether MRI alters the clinical diagnosis of inflammatory versus non-inflammatory back pain in an adolescent cohort of patients with back pain. Methods: A retrospective case note review was undertaken of all patients in the adolescent and young adult clinic undergoing conventional contrast enhanced MRI, with additional diffusion imaging of the SIJs, between January 2014 and January 2017. Patients without a pre-existing confirmed diagnosis of sacroiliitis were included in the study. The clinical impression before and after the MRI scan was noted.
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Results: A total of 204 patients (114 female and 90 male, median age 16 y 5 m) were included in the study. The number of patients diagnosed with sacroiliitis before and after MRI scan are shown in Table 1 . 53 patients (26%) had their diagnosis changed following MRI (Table 2) , with the clinical impression before the scan differing from the MRI result. 11.3% had a re-classification of their inflammatory condition post MRI, with active sacroiliitis identified in 23 patients (of 48 patients) with a pre-existing diagnosis of enthesitis related arthritis with peripheral arthritis only, resulting in a change in their disease status and treatment. Conclusions: The diagnosis of sacroiliitis based on clinical findings alone is not always accurate, with 26% of our patients having their diagnosis changed based on MRI. MRI of the SIJ is particularly important in patients with a pre-existing diagnosis of ERA with peripheral arthritis only, as in our study, sacroiliitis was identified in 23 patients. Though clinical impression plays an important role (accurate in 74%), the use of MRI scanning provides additional information that can improve the overall assessment and management of adolescents with back pain. Background: In adults, obesity has been found to be associated with an increase in the symptoms of chronic conditions. In particular, the symptoms of chronic musculoskeletal pain syndrome (Kumar et al., 2015) have been found to correlate with excess weight putting RESEARCH DAY ORAL ABSTRACTS PRESENTATIONS 4 October 2017 vi1
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